Tislelizumab in Combination With Sitravatinib in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

⟵ Back to Search Results

Beigene Study ID

BGB-A317-Sitravatinib 301

ClinicalTrials.gov ID

NCT04921358

Sex: All

Age: 18 Years and older (Adult, Older Adult)

No Study Documents

Locations

Sex: All

Age: 18 Years and older (Adult, Older Adult)

No Study Documents